R&D Systems™ Recombinant Human Thrombopoietin, ACFP Protein

Catalog No.	Quantity
ACFP288	50 μg

Catalog No. ACFP288 Supplier R&D Systems™ Supplier No. ACFP288

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human Thrombopoietin, ACFP Protein is derived from Sf 9 (baculovirus). The Recombinant Human Thrombopoietin, ACFP Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P40225
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 7066
• Molecular Weight (g/mol): 35 kDa
• Quantity: 50 μg
• Source: Spodoptera frugiperda,Sf 9 (baculovirus)-derived human Thrombopoietin/Tpo protein Ser22-Gly353 Produced in an animal component free process (ACFP).
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Gene Alias: Megakaryocyte colony-stimulating factor, Megakaryocyte growth and development factor, megakaryocyte stimulating factor, MGDF, MGDFC-mpl ligand, MKCSF, MK-CSF, ML, MPL ligand, MPLLG, MPLLGMGC163194, Myeloproliferative leukemia virus oncogene ligand, THCYT1, THPO, thrombopoietin, thrombopoietin nirs variant 1, Tpo, TPOMKCSF
• Gene Symbol: THPO
• Specific Reactivity: Thrombopoietin/THPO
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 100 μg/mL in 4 mM HCl.
• Buffer: Lyophilized from a 0.2 μm filtered solution in HCl.
• Purity or Quality Grade: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.